Search Results 81-90 of 13426 for Relaxin-2
... (2) Cohort 2 focuses on primary or secondary myelofibrosis (MF) displaying mutated calreticulin (muCALR); (3) Cohort 3 focuses on glioblastoma multiforme ...
About this study. The purpose of trhis study is to evaluate CPI-0610 in patients who have both received JAK inhibitors, such as ruxolitinib (Arms 1 and 2), ...
Phase 2 Study Of Ruxolitinib Versus Anagrelide In Subjects With Essential Thrombocythemia Who Are Resistant To Or Intolerant Of Hydroxyurea (RESET-272).
Creatinine ≤ 2 x ULN. SGOT (AST) ≤ 2 x ULN. Albumin ≥ 3 g/dL. Willing and able to provide research stool and blood samples. Negative serum pregnancy test ...
2/3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3) ...
... 2 of 2) 50 mcg IM suspension,201.71 636000003,58160082803,varicella-zoster glycop E vaccine (vial 2 of 2) 50 mcg IM suspension,201.7 636000003 ...
The purpose of this study is to assess the impact of a whole food plant-based diet on blood sugar control in diabetic patients versus a control group on the ...
This is a multi-center, open-label, Phase Ib dose escalation / Phase II study in recurrent or metastatic head and neck squamous cell carcinoma (RM HNSCC) ...
Feb; 157(2):710-2. This study was designed to evaluate the safety and efficacy of renal cryotherapy as a possible treatment of renal malignancy with ...
The purpose of this study is to evaluate the efficacy and safety of two different dosing regimens of AP26113 in patients with anaplastic lymphoma kinase (ALK)- ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.